July 20th 2023
GLP-1 RA safety alert
Off-label prescribing is "strongly discouraged"
MHRA has issued a patient safety alert for glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are in short supply until at least mid-2024.
The alert strongly discourage the off-label use of